info@talent4boards.com

– FRANCE, Strasbourg –

Transgene (Paris:TNG), a company that designs and develops viral-based immunotherapies, today announced the evolution and reinforcement of the Company’s Board of Directors. In the Annual General Meeting notice published today, Transgene’s Board of Directors has proposed a resolution to shareholders to appoint two new independent board members, Marie Landel and Maya Said.

- DisclaimerNews, data and statement included in this release are intended exclusively for information purposes. Product and brand names used in this release maybe trademarks or registered trade marks of their respective owners. Talent4Boards accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the adequacy or accuracy of this release. No data or statement in this release should be considered a recommendation for the purchase, retention or sale of the securities referred to herein.

Talent4Boards Team

here the original post =>

Comments are closed.